ENZYMATICA AB has a total of 54 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are TOP PHARM LAB, SUMMA HEALTH and HLI CELLULAR THERAPEUTICS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 6 | |
#3 | Australia | 5 | |
#4 | Brazil | 5 | |
#5 | United Kingdom | 5 | |
#6 | WIPO (World Intellectual Property Organization) | 5 | |
#7 | China | 4 | |
#8 | Republic of Korea | 4 | |
#9 | Canada | 3 | |
#10 | Denmark | 3 | |
#11 | Mexico | 3 | |
#12 | Russian Federation | 2 | |
#13 | Hungary | 1 | |
#14 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology | |
#4 | Organic fine chemistry | |
#5 | Basic materials chemistry | |
#6 | Environmental technology | |
#7 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Clarsund Mats Peter | 13 |
#2 | Stefansson Bjarki | 12 |
#3 | Gudmundsdottir Agusta | 12 |
#4 | Asgeirsson Asgeir | 9 |
#5 | Blom Ulf Thomas | 7 |
#6 | Sandholt Gunnar Birgir | 7 |
#7 | Scheving Reynir | 6 |
#8 | Guðmundsdóttir Ágústa | 5 |
#9 | Svensson Bo Roger | 5 |
#10 | Rasmussen Poul Baad | 5 |
Publication | Filing date | Title |
---|---|---|
GB201801982D0 | Novel treatments | |
GB201800274D0 | Novel treatments | |
GB201701315D0 | Novel treatments | |
EP3736331A1 | Novel trypsin isoforms and their use | |
KR20180031704A | Combination therapy | |
BR112016017478A2 | New treatments | |
GB201405784D0 | Novel methods, polypeptides and uses thereof | |
GB201401480D0 | Novel treatments |